Clonal evolution in myelodysplastic syndromes

نویسندگان

  • Pedro da Silva-Coelho
  • Leonie I Kroeze
  • Kenichi Yoshida
  • Theresia N Koorenhof-Scheele
  • Ruth Knops
  • Louis T van de Locht
  • Aniek O de Graaf
  • Marion Massop
  • Sarah Sandmann
  • Martin Dugas
  • Marian J Stevens-Kroef
  • Jaroslav Cermak
  • Yuichi Shiraishi
  • Kenichi Chiba
  • Hiroko Tanaka
  • Satoru Miyano
  • Theo de Witte
  • Nicole M A Blijlevens
  • Petra Muus
  • Gerwin Huls
  • Bert A van der Reijden
  • Seishi Ogawa
  • Joop H Jansen
چکیده

Cancer development is a dynamic process during which the successive accumulation of mutations results in cells with increasingly malignant characteristics. Here, we show the clonal evolution pattern in myelodysplastic syndrome (MDS) patients receiving supportive care, with or without lenalidomide (follow-up 2.5-11 years). Whole-exome and targeted deep sequencing at multiple time points during the disease course reveals that both linear and branched evolutionary patterns occur with and without disease-modifying treatment. The application of disease-modifying therapy may create an evolutionary bottleneck after which more complex MDS, but also unrelated clones of haematopoietic cells, may emerge. In addition, subclones that acquired an additional mutation associated with treatment resistance (TP53) or disease progression (NRAS, KRAS) may be detected months before clinical changes become apparent. Monitoring the genetic landscape during the disease may help to guide treatment decisions.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.

Myelodysplastic syndromes (MDS) with isolated deletion of chromosome arm 5q (del(5q)) have a good prognosis with low risk of transformation to acute myeloid leukemia (AML). Laboratory investigations typically demonstrate macrocytic anemia with preserved or increased platelet counts, and characteristic hypolobated megakaryocytes in the marrow (Figure 1A). Recent studies have provided significant...

متن کامل

Range Determination of Antigen Expression in Myeloid, Erythroid and Lymphoid Cell Lineages among Patients with Myelodysplastic Syndrome

Background: Myelodysplastic syndrome is a mixed clonal disorder of bone marrow progenitor cells. Understanding the pattern of the different lineage-specific, immature, and mature markers in myelodysplastic syndrome will help in setting-up the frame of reference to diagnose. Patients and Methods: We compared 60 bone marrow samples from 30 newly-diagnosed patients with myelodysplastic syndrome ...

متن کامل

Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report

Background Myelodysplastic syndromes are clonal myeloid disorders marked by ineffective hematopoiesis, cytopenia and qualitative disorders of blood cells that have a variable predilection to undergo clonal evolution to acute myelogenous leukemia. Chronic infection with hepatitis C virus (HCV) induces a chronic stimulation of B lymphocytes and, in some cases, this stimulation can lead to chronic...

متن کامل

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

In aplastic anemia (AA), contraction of the stem cell pool may result in oligoclonality, while in myelodysplastic syndromes (MDS) a single hematopoietic clone often characterized by chromosomal aberrations expands and outcompetes normal stem cells. We analyzed patients with AA (N = 93) and hypocellular MDS (hMDS, N = 24) using single nucleotide polymorphism arrays (SNP-A) complementing routine ...

متن کامل

Clinical and prognostic characterization of myelodysplastic syndromes

The myelodysplastic syndromes (MDS) provide a clinical model for evaluating the evolution of a relatively indolent malignancy into one which is frankly aggressive. The morbidity and mortality in this myeloid clonal hemopathy relate to either marrow dysfunction associated with ineffective hematopoiesis and its peripheral blood cytopenias or to disease evolution into a variant of acute myeloid le...

متن کامل

Aplastic anaemia evolving into myelodysplastic syndrome.

Acquired aplastic anaemia is a clonal disorder of multifactonal origin. The ~pathophysiology of this disorder is still not clear Presumably the multiple incriminating factors include an intrinsic derangement of haematopoiesis, immune mediated damage to bone marrow and genetic predisposition. The long term complications of the aplastic anaemia include clonal evolution into disorders like Paroxys...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2016